Tenon Medical, Inc. (TNON)

Market Cap	1.80M -82.3%
Revenue (ttm)	5.31M +80.3%
Net Income	-13.70M
EPS	-46.67
Shares Out	667.05K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	244,123
Open	2.800
Previous Close	2.860
Day's Range	2.670 - 2.879
52-Week Range	2.400 - 50.400
Beta	1.36
Analysts	Buy
Price Target	44.38 (+1,543.7%)
Est. Earnings	Nov 12, 2026

About TNON

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along it...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 27, 2022
• Employees: 26
• Stock Exchange: NASDAQ
• Ticker Symbol: TNON
• Website: https://www.tenonmed.com

Financial Performance

In 2025, Tenon Medical's revenue was $3.94 million, an increase of 20.35% compared to the previous year's $3.28 million. Losses were -$12.56 million, -8.17% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for TNON stock is "Buy." The 12-month stock price target is $44.38, which is an increase of 1,543.70% from the latest price.

Price Target

$44.38

(1,543.70% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Sep 29, 2026

Data Sources Report a data error